Top compounds associated with response to MYT1


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 1e-07
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 2e-07
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 5e-07
mRNA tacedinaline CTRPv2 pan-cancer AAC 0.21 5e-07
mRNA PD-0325901 gCSI pan-cancer AAC -0.25 7e-07
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 9e-07
mRNA NSC95397 CTRPv2 pan-cancer AAC 0.18 1e-06
mRNA 17-AAG GDSC1000 pan-cancer AAC -0.16 1e-06
mRNA NPK76-II-72-1 GDSC1000 pan-cancer AAC 0.15 1e-06
mRNA Parthenolide CTRPv2 pan-cancer AAC 0.2 1e-06
Download CSV